Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > THTX for retail investors

<< Previous

Bullboard Posts

Next >>

Comment by houbahopon Feb 08, 2021 10:51am

129 Views

Post# 32500334

RE:RE:RE:THTX for retail investors

I have traded TH shares many times since 1998.

This is an entry position. If it starts to trade over $4, I would add to my position.

Looking at a 20-years+ chart, 3 times it traded at $2 before a rally that brought the shares at $12.
Time is irrelevant for me. Sell target would be $12. Stop loss around $2.

A two year time horizon would probably do the job.

Txs for asking,

Houba

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)